Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced this week that it has formed the Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation sequencing clinical research panels designed to help identify predictive and prognostic biomarkers associated with cancer immunotherapy. The consortium brings together a group of clinical researchers from institutions in Europe.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.